NASDAQ:ROIV

Roivant Sciences Stock Insider Trading

etoro logo Buy ROIV
*Your capital is at risk
$31.25
-0.180 (-0.573%)
At Close: Jun 22, 2026

Roivant Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -82.45. In total, the insiders bought 21.24M and sold 13.61M ROIV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-82.45
Buy 21.24M shares
Sell 13.61M shares
45% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Mar 30, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -82.45.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 20, 2026
Sell
Common Shares
F-InKind
Momtazee James C
Director
Director 122
Value: $3K
Jan 12, 2026
Sell
Common Shares
S-Sale
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $4.38M
Jan 12, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $770.0K
Jan 12, 2026
Buy
Common Shares
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $770.0K
Dec 31, 2025
Buy
Common Shares
M-Exempt
Sukhatme Mayukh
President & Cio
CEO / President 2 449 877
Value: $31.1M
Dec 31, 2025
Sell
Common Shares
S-Sale
Sukhatme Mayukh
President & Cio
CEO / President 1 018 995
Value: $22.1M
Dec 31, 2025
Sell
Common Shares
J-Other
Sukhatme Mayukh
President & Cio
CEO / President 1 430 882
Value: $31.1M
Dec 31, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Sukhatme Mayukh
President & Cio
CEO / President 2 449 877
Value: $31.1M
Dec 29, 2025
Buy
Common Shares
M-Exempt
Sukhatme Mayukh
President & Cio
CEO / President 748 358
Value: $9.49M
Dec 29, 2025
Sell
Common Shares
S-Sale
Sukhatme Mayukh
President & Cio
CEO / President 311 873
Value: $6.78M
Dec 29, 2025
Sell
Common Shares
J-Other
Sukhatme Mayukh
President & Cio
CEO / President 436 485
Value: $9.49M
Dec 29, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Sukhatme Mayukh
President & Cio
CEO / President 748 358
Value: $9.49M
Dec 24, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 117 848
Value: $453.7K
Dec 24, 2025
Sell
Common Shares
J-Other
Torti Frank
President And Vant Chair
CEO / President 64 891
Value: $1.46M
Dec 24, 2025
Sell
Common Shares
G-Gift
Torti Frank
President And Vant Chair
CEO / President 110 489
Value: $0
Dec 24, 2025
Buy
Common Shares
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 117 848
Value: $453.7K
Dec 24, 2025
Sell
Common Shares
S-Sale
Venker Eric
President & Immunovant CEO
CEO / President 75 000
Value: $1.69M
Dec 23, 2025
Buy
Common Shares
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 313 841
Value: $1.21M
Dec 23, 2025
Buy
Common Shares
A-Award
Torti Frank
President And Vant Chair
CEO / President 175 380
Value: $3.94M
Dec 23, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Pulik Richard
CFO
C-Suite Officer 260 000
Value: $1.00M
Dec 23, 2025
Buy
Common Shares
M-Exempt
Pulik Richard
CFO
C-Suite Officer 260 000
Value: $1.00M
Dec 23, 2025
Sell
Common Shares
S-Sale
Pulik Richard
CFO
C-Suite Officer 260 000
Value: $5.84M
Dec 23, 2025
Sell
Common Shares
S-Sale
Pulik Richard
CFO
C-Suite Officer 146 731
Value: $3.29M
Dec 23, 2025
Buy
Stock Option (Right to Buy)
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 313 841
Value: $1.21M
Dec 23, 2025
Sell
Common Shares
S-Sale
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $4.49M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ROIVANT SCIENCES LTD.
Roivant Sciences
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aur...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE